EP PerMed conducted the first in a series of in-situ visits on 11 and 12 November 2024 in Stockholm, Sweden.
The EP PerMed in-situ visits in selected personalised medicine centres specifically aim at:
- Providing real life examples of successful personalised medicine research, innovation and its implementation into healthcare systems.
- Inform EP PerMed stakeholders’ community about ongoing activities in EU member states.
- Foster the exchange of best practice among national and regional centres and in general among stakeholders involved in the personalised medicine value continuum.
- Promote the growth of less advanced personalised medicine centres or help setting the basis for future initiatives.
- Favour the involvement of funding agencies and decision makers in the International Consortium for Personalised Medicine (ICPerMed)
- Strengthen existing collaborations or promote the creation of new ones.
- Through dialogue identify needs and opportunities that can support future updates of the EP PerMed Strategic Research and Innovation Agenda (SRIA) and future activities.
Report
Regional Precision Medicine Centres building on Genomic Medicine Sweden (Sweden)
Genomic Medicine Sweden (GMS) is a national infrastructure for the implementation of precision medicine across the country which started 2018. This initiative has since then expanded and regional Precision Medicine centres are being established where GMS is a central component.
Through regional centres for genomic medicine at all Swedish university hospitals and a common infrastructure for data sharing, GMS has built up the capacity for precision diagnostics/medicine in rare diseases, cancer, infectious diseases and complex diseases.
Recordings
Day 1, 11 November 2024
Topic: Welcome and introductions
Speaker: Laurent Saunier & Malin Eklund
Role/title: Vinnova: Head of Health Dept & International collaboration health
Topic: Welcome and introductions
Speaker: EP PerMed + IC PerMed
Role/title: WP5 and Coordination
Topic: Setting the stage: the systems change of precision medicine
Speaker: Anna Wedell
Role/title: Professor/Senior consultant, Center for Inherited Metabolic Diseases (CMMS), Karolinska University Hospital Director, Precision Medicine Center Karolinska (PMCK)
Topic: The rise and perspectives of Genomic Medicine Sweden
Speaker: Richard Rosenquist Brandell
Role/title: Professor/Senior Consultant, Clinical Genetics and Genomics, Karolinska University Hospital, Director Genomic Medicine Sweden (GMS)
Topic: Individual patient journey. Patient and citizen engagement.
Speaker: Karin Liljelund
Role/title: The Lung Cancer Association
Topic: A real-life case and Precision Medicine Centre Karolinska (PMCK) – Strategies for implementation into everyday healthcare
Speaker: Anna Wedell
Role/title: Professor/Senior consultant, Center for Inherited Metabolic Diseases (CMMS), Karolinska University Hospital Director, Precision Medicine Center Karolinska (PMCK)
Topic: Systems perspectives through data on precision health & medicine in Region Halland
Speaker: Helena Linge
Role/title: Strategist, Research and Education, Region Halland
Associate professor molecular medicine, Lund university
Topic: Next step: Roadmap for implementation of PM in healthcare
Speaker: Helena Nilsson
Role/title: Head of Development, Healthcare Region Örebro
Topic: Panel discussion day 1
Day 2, 12 November 2024
Topic: Welcome to SciLifeLab
Speaker: Sandra Falck
Role/title: Vice Head of Operations, SciLifeLab
Topic: SciLifeLab Precision Medicine Capability – current and future perspectives
Speaker: Päivi Östling
Role/title: Scientific Lead for Precision Medicine at SciLifeLab, Karolinska Institute
Topic: New technology driven Precision medicine at SciLifeLab
Speaker: Janne Lehtiö
Role/title: Scientific Lead for Precision Medicine at SciLifeLab, Karolinska Institute
Topic: Connecting the PM Ecosystem: ATMP, PRECISE EU and beyond
Speaker: Kristina Levan
Role/title: Director Sahlgrenska ATMP center
Topic: Industry perspective, clinical trials
Speaker: Frida Lundmark
Role/title: Policy Expert at Lif – the trade association for research-based pharma industry in Sweden
Topic: Panel discussion and wrap-up of the day
Agenda
Day 1, 11 November 2024
| Speaker | Role/title | Topic |
|---|---|---|
| Laurent Saunier & Malin Eklund | Vinnova: Head of Health Dept & International collaboration health | Welcome and introductions |
| EP PerMed + IC PerMed | WP5 and Coordination | |
| Anna Wedell | Professor/Senior consultant, Center for Inherited Metabolic Diseases (CMMS), Karolinska University Hospital Director, Precision Medicine Center Karolinska (PMCK) | Setting the stage: the systems change of precision medicine |
| Richard Rosenquist Brandell | Professor/Senior Consultant, Clinical Genetics and Genomics, Karolinska University Hospital, Director Genomic Medicine Sweden (GMS) | The rise and perspectives of Genomic Medicine Sweden |
| Karin Liljelund | The Lung Cancer Association | Individual patient journey. Patient and citizen engagement. |
| Anna Wedell | Head of Precision Medicine Center Karolinska (PMCK), see above | A real-life case and Precision Medicine Centre Karolinska (PMCK) – Strategies for implementation into everyday healthcare |
| Helena Linge | Strategist, Research and Education, Region Halland Associate professor molecular medicine, Lund university | Systems perspectives through data on precision health & medicine in Region Halland |
| Helena Nilsson | Head of Development, Healthcare Region Örebro | Next step: Roadmap for implementation of PM in healthcare |
| Panel discussion day 1 | ||
| Tour: Center of Imaging Research (CIR) Daniel Lundqvist, Director of CIR | ||
Day 2, 12 November 2024
| Speaker | Role/title | Topic |
|---|---|---|
| Sandra Falck | Vice Head of Operations, SciLifeLab | Welcome to SciLifeLab |
| Päivi Östling | Scientific Lead for Precision Medicine at SciLifeLab, Karolinska Institute | SciLifeLab Precision Medicine Capability – current and future perspectives |
| Janne Lehtiö | Scientific Lead for Precision Medicine at SciLifeLab, Karolinska Institute | New technology driven Precision medicine at SciLifeLab |
| Kristina Levan | Director Sahlgrenska ATMP center | Connecting the PM Ecosystem: ATMP, PRECISE EU and beyond |
| Frida Lundmark | Policy Expert at Lif – the trade association for research-based pharma industry in Sweden | Industry perspective, clinical trials |
| Panel discussion and wrap-up of the day | ||